ArticleBMC psychiatry2025
Anxiety and depression one year after the first stroke among Lebanese survivors: proportions, changes, and predictors.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical Characteristics and Influencing Factors of Depressive Symptoms in Patients With Vascular Cognitive Impairment.Actas espanolas de psiquiatria · 2026Observational
- Latent profile analysis of depression and anxiety comorbidity in patients with acute ischemic stroke: a prospective study.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAbout 1 in 2 stroke survivors suffer from anxiety and depression in the first year after stroke. This study aimed to calculate the proportions of 1-year post-stroke anxiety and depression (PSA and PSD), evaluate their changes over time, and identify the contributing factors among first-ever stroke survivors in Lebanon, where relevant research has been scarce.
methodsA hospital-based multicenter study was conducted among 150 subjects aged ≥ 18 years involving scheduled home visits at 3, 6, and 12 months after stroke index. Several scales were employed, including Hospital Anxiety and Depression Scale (HADS), Mini-Mental State Examination (MMSE), modified Rankin Scale (mRS), Short Form Health Survey (SF12), National Institutes of Health Stroke Scale (NIHSS), Visual Analogue Scale (VAS), Douleur Neuropathique 4 (DN4), Modified Ashworth Scale (MAS), and Fatigue Severity Scale (FSS), to assess levels of anxiety and depression, cognitive function, disability degree, quality of life, stroke severity, general pain, central pain, spasticity, and fatigue after stroke, respectively. Descriptive analyses were performed to describe baseline and stroke characteristics and to calculate proportions of PSA and PSD, followed by univariate and multivariable analyses to identify the contributing factors.
resultsHigh HADS scores were reported in our cohort, with the most prevalent symptoms occurring within the first 3 months after stroke index (77.3% for PSD and 51.2% for PSA with HADS ≥ 8). Despite a slight decrease over the subsequent 6 and 12 months, proportions remained elevated, affecting at least 40% to 60% of survivors. PSA was a consistent independent predictor of PSD (Adjusted Odds Ratio ≅ 2). Other contributing factors to PSA and PSD were highlighted, including a history of atrial fibrillation, longer sedentary hours, high scores of NIHSS and mRS, lower scores of SF12 and MMSE, and the presence of immobility-related problems, of which high DN4 scores were independent predictors. Better 1-year psychological outcomes were noticed in those with higher educational levels and employment after stroke.
conclusionRoutine psychological screening and support for stroke survivors are urgently needed. By identifying factors and emphasizing early detection, our research offers valuable insights that can inform clinical practice and improve the well-being of stroke survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.